Steven Spergel

2PUBLICATIONS
4CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 19, 2019
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165.

Stephen T Wrobleski, Ryan Moslin, Shuqun Lin

|Jul 18, 2019
Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2).

Ryan Moslin, Yanlei Zhang, Stephen T Wrobleski

Pageof 1

Frequent Collaborators

2 joint publications

Ryan Moslin

2 joint publications

Stephen T Wrobleski

2 joint publications

Percy H Carter

1 joint publications

James Kempson